| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Emergent Biosolutions Inc. (EBS) has 12 insiders with recent SEC Form 4 filings, including 0 buys and 22 sells. EBS is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 374.1K | $3.11M | - | |
| CEO | 305.4K | $2.54M | - | |
| VP | 202.2K | $1.68M | - | |
| VP | 185.6K | $1.54M | - | |
| VP | 162.1K | $1.35M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 13, 2016 | Richard Ronald | Director | Sell | 5,900 | $34.09 | $201,106.54 | -16.3% | |
| Jun 6, 2016 | Joulwan George A | Director | Sell | 4,700 | $44.12 | $207,364.00 | -18.4% | |
| Jun 1, 2016 | Abdun-Nabi Daniel | President &CEO | Sell | 8,699 | $43.74 | $380,494.26 | -4.8% | |
| May 27, 2016 | El-Hibri Fuad | Chairman | Sell | 9,835 | $43.50 | $427,822.50 | -0.6% | |
| May 26, 2016 | El-Hibri Fuad | Chairman | Sale+OE | 39,759 | $43.13 | $1,714,760.10 | -1.2% | |
| May 25, 2016 | Harsanyi Zsolt | Director | Sale+OE | 27,867 | $42.33 | $1,179,511.47 | -13.9% | |
| May 25, 2016 | El-Hibri Fuad | Chairman | Sale+OE | 85,000 | $42.52 | $3,614,300.00 | -1.2% | |
| May 20, 2016 | Abdun-Nabi Daniel | President &CEO | Sell | 8,701 | $42.00 | $365,442.00 | -4.6% | |
| May 19, 2016 | Hauer Jerome M | Director | Sell | 3,134 | $41.22 | $129,183.48 | -15.6% | |
| May 13, 2016 | Sullivan Louis W62 | Director | Sale+OE | 47,631 | $39.21 | $1,867,761.00 | -29.5% |